Download - WHOCC
Download - WHOCC
Download - WHOCC
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
QL02<br />
ENDOCRINE THERAPY<br />
Only preparations used specifically in the treatment of neoplastic diseases should<br />
be classified in this group. This means that some strength might be assigned to this<br />
group, while other strengths would be classified in QG03 - Sex hormones and<br />
modulators of the genital system. Gonadotropin-releasing hormone (GnRH) and<br />
analogues not used in endocrine therapy are classified in QH01CA.<br />
QL02A<br />
QL02AA<br />
QL02AB<br />
QL02AE<br />
HORMONES AND RELATED AGENTS<br />
Estrogens<br />
Progestogens<br />
Gonadotropin releasing hormone analogues<br />
In the ATCvet system, the proper classification of buserelin is in QH01CA.<br />
QL02AX<br />
Other hormones<br />
QL02B<br />
QL02BA<br />
QL02BB<br />
QL02BG<br />
QL02BX<br />
HORMONE ANTAGONISTS AND RELATED AGENTS<br />
Anti-estrogens<br />
Anti-androgens<br />
Enzyme inhibitors<br />
Other hormone antagonists and related agents<br />
QL03<br />
QL03A<br />
IMMUNOMOSTIMULANTS<br />
IMMUNOSTIMULANTS<br />
Levamisole, which also affects the immune response, is classified in<br />
QP52 - Anthelmintics.<br />
QL03AA<br />
QL03AB<br />
Colony stimulating factors<br />
Interferons<br />
Peginterferon alfa-2b in combination with ribavirin and peginterferon alfa-2a in<br />
combination with ribavirin are classified in QL03AB60 and QL03AB61,<br />
respectively.<br />
QL03AC<br />
Interleukins<br />
130
Change language